[Andrews ZB. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci 34, 31–40, 2011.10.1016/j.tins.2010.10.00121035199]Open DOISearch in Google Scholar
[Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21, 7724–7732, 2001.10.1523/JNEUROSCI.21-19-07724.2001]Open DOISearch in Google Scholar
[Babri S, Mohaddes G, Alipour MR, Ebrahimi H, Hossenzadeh F. Effects of ghrelin on plasma glucose levels, body weight, food intake and hematocrit in acute and chronic systemic hypoxia in adult male rats. Iran J Endocrinol Metab 15, 100–106, 2013.]Search in Google Scholar
[Bansal V. Ryu SY, Blow C, Costantini T, Loomis W, Elicerri B, Baird A, Wolf P, Coimbra R. The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction. J Neurotrauma 27, 2255–2260, 2010.10.1089/neu.2010.1372]Open DOISearch in Google Scholar
[Bauer AT, Burgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30, 837–848, 2010.10.1038/jcbfm.2009.248]Search in Google Scholar
[Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63, 5224–5229, 2003.]Search in Google Scholar
[Bond M, Chase A, Baker AH, Newby AC. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50, 556–565, 2001.10.1016/S0008-6363(01)00220-6]Search in Google Scholar
[Brywe KG, Leverin AL, Gustavsson M, Mallard C, Granata R, Destefanis S, Volante M, Hagberg H, Ghigo E, Isgaard J. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3 beta phosphorylation. Endocrinology 146, 4665–4672, 2005.10.1210/en.2005-0389]Search in Google Scholar
[Carlini VP, Monzon ME, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 299, 739–743, 2002.10.1016/S0006-291X(02)02740-7]Search in Google Scholar
[Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35, 258–265, 2011.2072051210.1097/SHK.0b013e3181f48a3720720512]Search in Google Scholar
[Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148, 148–159, 2007.10.1210/en.2006-09911705302417053024]Open DOISearch in Google Scholar
[Chung H, Seo S, Moon M, Park S. Phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 198, 511–521, 2008.10.1677/JOE-08-016018541646]Search in Google Scholar
[Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329–339, 2005.1584680210.1002/glia.2016915846802]Search in Google Scholar
[Diano S, Farr SS, Benoit SC, McNay EC, Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks MA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL. Ghrelin controls hippo-campal spine synapse density and memory performance. Nat Neurosci 9, 381–388, 2006.10.1038/nn165616491079]Open DOISearch in Google Scholar
[Duansak N, Schmid-Schonbein GW. The oxygen free radicals control MMP-9 and transcription factors expression in the spontaneously hypertensive rat. Microvasc Res 90, 154–161, 2013.10.1016/j.mvr.2013.09.00324060804464299824060804]Open DOISearch in Google Scholar
[Duran-Vilaregut J, del Valle J, Manich G, Camins A, Pallas M, Vilaplana J, Pelegri C. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington’s disease. Neuropathol Appl Neurobiol 37, 525–537, 2011.10.1111/j.1365-2990.2010.01157.x21175737]Search in Google Scholar
[Ersahin M, Toklu HZ, Erzik C, Cetinel S, Akakin D, Velioglu-Ogunc A, Tetik S, Ozdemir ZN, Sener G, Yegen BC. The antiinflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J Neurotrauma 27, 1143–1155, 2010.10.1089/neu.2009.121020205513]Open DOISearch in Google Scholar
[Feizi H, Rajaee K, Keyhanmanesh R, Aliparasti MR, Almasi S, Alipour MR. Effect of ghrelin on renal erythropoietin production in chronic hypoxic rats. Endocr Regul 48, 3–8, 2014.2452437010.4149/endo_2014_01_324524370]Search in Google Scholar
[Fry M, Ferguson AV. Ghrelin: central nervous system sites of action in regulation of energy balance. Int J Pept 2010, 2010.10.1155/2010/616757292508220798749]Search in Google Scholar
[Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21, 1393–1400, 2001.10.1097/00004647-200112000-0000311740200]Search in Google Scholar
[Hossienzadeh F, Babri S, Alipour MR, Ebrahimi H, Mohaddes G. Effect of ghrelin on brain edema induced by acute and chronic systemic hypoxia. Neurosci Lett 534, 47–51, 2013.10.1016/j.neulet.2012.11.06223295905]Search in Google Scholar
[Higashida T, Kreipke CW, Rafols JA, Peng C, Schafer S, Schafer P, Ding JY, Dornbos D 3rd, Li X, Guthikonda M, Rossi NF, Ding Y. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg 114, 92–101, 2011.10.3171/2010.6.JNS1020720617879]Open DOISearch in Google Scholar
[Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, Li HT, Wang T. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30, 2286–2291, 2009.10.1016/j.peptides.2009.09.00419747956]Open DOISearch in Google Scholar
[Kheradmand A, Alirezaei M, Birjandi M. Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary. Regul Pept 162, 84–89, 2010.10.1016/j.regpep.2010.02.008]Search in Google Scholar
[Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660, 1999.10.1038/45230]Search in Google Scholar
[Lee JY, Choi HY, Na WH, Ju BG, Yune TY. Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury. Biochim Biophys Acta 1842, 2403–2412, 2014.10.1016/j.bbadis.2014.09.006]Search in Google Scholar
[Liu Y, Wang PS, Xie D, Liu K, Chen L. Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. Chin J Physiol 49, 244–250, 2006.]Search in Google Scholar
[Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun 359, 795–800, 2007.10.1016/j.bbrc.2007.05.192]Search in Google Scholar
[Mohaddes G, Abdolalizadeh J, Babri S, Abedini N, Hossienzadeh F. The anti-edematous effect of ghrelin in brain hypoxia is associated with decreasing expression of vascular endothelial growth factor. J Mol Neurosci 56, 273–277, 2015.2572578610.1007/s12031-015-0528-3]Search in Google Scholar
[Mohaddes G, Abdolalizadeh J, Babri S, Hossienzadeh F. Ghrelin ameliorates blood-brain barrier disruption during systemic hypoxia. Exp Physiol 102, 376–382, 2017.10.1113/EP086068]Open DOISearch in Google Scholar
[Park SL, Won SY, Song JH, Kambe T, Nagao M, Kim WJ, Moona SK. EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells. Cell Signal 27, 470–478, 2015.10.1016/j.cellsig.2014.12.001]Search in Google Scholar
[Reszec J, Hermanowicz A, Rutkowski R, Turek G, Mariak Z, Chyczewski L. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. Biomed Res Int 2015, 2015.10.1155/2015/646853]Search in Google Scholar
[Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8, 205–216, 2009.10.1016/S1474-4422(09)70016-X]Search in Google Scholar
[Sato T, Ito A, Ogata Y, Nagase H, Mori Y. Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNF alpha. FEBS Lett 392, 175–178, 1996.10.1016/0014-5793(96)00808-3]Search in Google Scholar
[Sifringer M, Genz K, Brait D, Brehmer F, Lober R, Weichelt U, Kaindl AM, Gerstner B, Felderhoff-Mueser U. Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Dev Neurosci 31, 394–402, 2009.10.1159/000232557]Search in Google Scholar
[Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, Yong VW. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 61, 212–224, 2000.10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9]Search in Google Scholar
[Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83, 832–840, 1998.10.1161/01.RES.83.8.832]Search in Google Scholar
[Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20, 7037–7042, 2000.10.1523/JNEUROSCI.20-18-07037.2000]Open DOISearch in Google Scholar
[Wu H, Dong G, Liu H, Xu B, Li D, Jing H. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol 602, 406–412, 2009.10.1016/j.ejphar.2008.11.037]Search in Google Scholar
[Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27, 697–709, 2007.10.1038/sj.jcbfm.9600375]Search in Google Scholar
[Zhang Q, Huang C, Meng B, Tang T, Shi Q, Yang H. Acute effect of ghrelin on ischemia/reperfusion injury in the rat spinal cord. Int J Mol Sci 13, 9864–9876, 2012.10.3390/ijms1308986422949835]Open DOISearch in Google Scholar
[Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494, 528–548, 2006.10.1002/cne.20823]Search in Google Scholar